27 related articles for article (PubMed ID: 458947)
1. Estramustine phosphate sodium. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer.
Perry CM; McTavish D
Drugs Aging; 1995 Jul; 7(1):49-74. PubMed ID: 7579781
[TBL] [Abstract][Full Text] [Related]
2. The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation.
Murphy GP; Gibbons RP; Johnson DE; Prout GR; Schmidt JD; Soloway MS; Loening SA; Chu TM; Gaeta JF; Saroff J; Wajsman Z; Slack N; Scott WW
Trans Am Assoc Genitourin Surg; 1978; 70():69-71. PubMed ID: 753026
[TBL] [Abstract][Full Text] [Related]
3. New steroidal alkylating agents in advanced stage D carcinoma of the prostate.
Mittelman A; Catane R; Murphy GP
Cancer Treat Rep; 1977; 61(2):307-10. PubMed ID: 872134
[TBL] [Abstract][Full Text] [Related]
4. Combined therapy of advanced prostatic carcinoma with estramustine and prednimustine.
Catane R; Kaufman J; Mittelman A; Murphy GP
J Urol; 1977 Mar; 117(3):332-5. PubMed ID: 839597
[TBL] [Abstract][Full Text] [Related]
5. Comparison of estramustine phosphate and vincristine alone or in combination for patients with advanced, hormone refractory, previously irradiated carcinoma of the prostate.
Soloway MS; deKernion JB; Gibbons RP; Johnson DE; Loening SA; Pontes JE; Prout GR; Schmidt JD; Scott WW; Chu TM; Gaeta JF; Slack NH; Murphy GP
J Urol; 1981 May; 125(5):664-7. PubMed ID: 7230336
[TBL] [Abstract][Full Text] [Related]
6. Prednimustine for prostate cancer therapy.
Slack NH; Murphy GP
Compr Ther; 1979 Sep; 5(9):54-7. PubMed ID: 487742
[No Abstract] [Full Text] [Related]
7. The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation.
Murphy GP; Gibbons RP; Johnson DE; Prout GR; Schmidt JD; Soloway MS; Loening SA; Chu TM; Gaeta JF; Saroff J; Wajsman Z; Slack N; Scott WW
J Urol; 1979 Jun; 121(6):763-5. PubMed ID: 458947
[TBL] [Abstract][Full Text] [Related]
8. The use of estramustine phosphate in the modern management of advanced prostate cancer.
Ravery V; Fizazi K; Oudard S; Drouet L; Eymard JC; Culine S; Gravis G; Hennequin C; Zerbib M
BJU Int; 2011 Dec; 108(11):1782-6. PubMed ID: 21756277
[TBL] [Abstract][Full Text] [Related]
9. Clinical toxicity and long-term results of Emcyt therapy for prostate cancer.
Slack NH; Murphy GP
Urology; 1984 Jun; 23(6 Suppl):73-7. PubMed ID: 6375085
[No Abstract] [Full Text] [Related]
10. The chemotherapy of prostatic adenocarcinoma.
Torti FM; Carter SK
Ann Intern Med; 1980 May; 92(5):681-9. PubMed ID: 6992675
[TBL] [Abstract][Full Text] [Related]
11. Prednimustine in advanced breast cancer: a review.
Mouridsen HT
Semin Oncol; 1986 Mar; 13(1 Suppl 1):27-31. PubMed ID: 3513318
[TBL] [Abstract][Full Text] [Related]
12. Estramustine phosphate and other cytotoxic drugs in the treatment of poor prognostic advanced prostate cancer.
Janknegt RA
Prostate Suppl; 1992; 4():105-10. PubMed ID: 1574449
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]